Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3032057	f-cldiseul	— (—)	832	1080	100.00%	Distribution not available
3032057	f-cldiag	— (—)	354	444	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Bacterial infection, other or unspecified

252

318

6.73

148.53

2.2

1.5

—

Bacterial infection, other or unspecified, including avohilmo

258

335

6.35

142.36

2.2

1.5

—

Oxycodone

190

235

6.96

116.20

2.0

1.7

—

Intestinal infectious diseases, including avohilmo, including avohilmo

345

432

4.46

112.32

2.0

1.7

—

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

302

447

4.34

101.30

1.9

1.7

—

Other bacterial intestinal infections, including avohilmo

138

176

7.92

101.00

2.5

1.7

—

Enterocolitis due to Clostridium difficile

104

11.52

100.18

2.7

1.7

—

Other bacterial diseases

285

426

4.44

99.45

2.1

1.6

—

Infections, IBD-co-morbidities

21.51

95.16

2.8

1.7

—

Other bacterial intestinal infections

118

136

8.78

93.85

2.7

1.7

—

Intestinal infectious diseases

288

535

4.01

92.51

2.2

1.6

—

Bacterial intestinal infections, IBD co-morbidities

120

150

8.09

89.38

2.6

1.7

—

Other bacterial diseases, including avohilmo

275

424

4.06

84.09

2.0

1.6

—

Budesonide

10.60

80.45

1.9

1.8

—

Septicaemia

160

272

5.39

78.44

2.4

1.5

—

Diarrhoea and gastroenteritis of presumed infectious origin

217

475

4.09

76.06

2.1

1.6

—

Other septicaemia

149

257

5.50

75.53

2.4

1.5

—

Other septicaemia, including avohilmo

150

259

5.46

75.45

2.4

1.5

—

Irritable bowel syndrome

105

138

7.65

74.90

1.6

1.9

—

Medical observation and evaluation for suspected diseases and conditions

179

158

5.81

73.05

1.8

—

Noninfective enteritis and colitis

167

357

4.69

72.17

2.0

1.7

—

Implicit bacterial Sepsis, including avohilmo

172

305

4.71

70.20

2.0

1.6

—

Bacterial Sepsis

173

311

4.62

68.83

2.0

1.6

—

Fever of other and unknown origin

168

315

4.63

68.29

2.3

1.7

—

Explicit Sepsis

162

320

4.63

66.87

2.4

1.6

—

Explicit Sepsis, including avohilmo

163

324

4.58

66.29

2.4

1.6

—

Implicit Sepsis

215

412

3.85

65.46

1.8

1.6

—

Implicit bacterial Sepsis

160

296

4.66

65.12

2.0

1.6

—

Other diseases of intestines

248

372

3.72

65.01

1.8

—

Inflammatory bowel disease treatment related agents

280

466

3.34

62.99

2.0

1.7

—

First line medication for Crohn's disease

255

392

3.51

60.84

2.0

1.6

—

ILD medications: prednisolone, methylprednisolone, prednisone

261

429

3.39

60.06

2.0

1.6

—

Oral corticosteroids

261

460

3.33

59.79

2.0

1.7

—

5-aminosalicylic acid

114

7.51

59.64

2.2

1.8

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

253

521

3.28

59.31

2.1

1.7

—

Other functional intestinal disorders

143

286

4.56

57.97

1.8

1.7

—

Certain infectious and parasitic diseases

201

243

4.15

57.85

2.0

1.4

—

ILD medications

263

430

3.30

57.65

2.0

1.6

—

208

325

3.75

56.20

1.9

1.7

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

208

325

3.75

56.20

1.9

1.7

—

Any gastric operation

149

145

5.16

54.21

2.1

1.5

—

GASTRO-related operations

149

145

5.16

54.21

2.1

1.5

—

Gastro-oesophageal reflux disease

186

437

3.60

53.82

1.9

1.7

—

Influenza and pneumonia

240

458

3.24

53.66

2.0

1.7

—

IBD patients in KELA-register

135

6.48

53.43

2.1

1.9

—

Implicit Sepsis, including avohilmo

209

437

3.42

53.37

1.8

1.6

—

Pneumonia, organism unspecified

215

445

3.32

51.73

1.9

1.7

—

Inflammatory bowel disease, strict (require KELA)

143

6.12

50.51

2.1

2.0

—

Ulcerative colitis, NAS

8.32

50.46

2.2

2.0

—

Unspecified urinary incontinence

8.98

50.20

1.8

—

All pneumoniae

228

475

3.12

49.04

1.9

1.7

—

Pneumonias (Asthma/COPD co-morbidities)

225

475

3.10

47.87

1.9

1.7

—

Diseases of oesophagus, stomach and duodenum

247

494

2.96

47.09

1.9

1.8

—

Symptoms and signs involving the urinary system

205

494

3.14

46.51

1.8

—

Erysipelas

143

323

3.83

45.54

2.1

1.5

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

219

485

3.01

44.77

1.9

1.7

—

Complications of surgical and medical care, not elsewhere classified

240

562

2.85

44.76

2.1

1.7

—

ILD medications: immunosuppressive drugs

147

364

3.67

44.71

2.3

1.6

—

Other noninfective gastroenteritis and colitis

189

5.00

43.92

2.0

1.8

—

Heart failure, not strict

182

371

3.30

43.31

2.0

1.7

—

Certain infectious and parasitic diseases, including avohilmo

129

138

4.69

42.71

2.0

1.4

—

General symptoms and signs

217

349

3.12

42.64

1.9

1.7

—

Inflammatory bowel disease

105

239

4.41

42.27

2.1

1.8

—

Other and unspecified disorders of skin and subcutaneous tissue

10.62

42.02

2.5

2.1

—

Complications of medical and surgical care

191

575

2.99

41.99

2.2

1.7

—

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

102

6.61

41.96

2.2

2.0

—

Transplanted organ and tissue status

10.32

41.31

3.1

1.9

—

Other disorders of skin and subcutaneous tissue, not elsewhere classified

111

6.27

41.00

2.3

1.8

—

Condition for Implicit Sepsis (Organ dysfunction codes)

194

444

3.03

40.67

1.8

1.7

—

Any death

163

339

3.37

40.55

2.1

1.6

—

Renal tubulo-interstitial diseases

206

525

2.88

40.18

2.1

1.7

—

Special screening examination for infectious and parasitic diseases

8.84

39.87

2.0

1.9

—

Other symptoms and signs involving the digestive system and abdomen

6.57

39.87

1.9

1.7

—

Hernia of abdominal wall, postoperative

8.88

39.42

2.5

1.5

—

Continuous positive airway pressure

7.61

39.36

1.7

1.9

—

COPD/asthma/ILD related infections

201

325

3.10

39.21

1.9

1.7

—

COPD/asthma related infections

201

325

3.10

39.21

1.9

1.7

—

Diverticular disease of intestine

166

310

3.34

39.21

1.8

—

Ulcerative colitis (strict definition, require KELA)

6.54

39.05

2.2

2.0

—

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

6.64

39.00

2.2

2.0

—

Autoimmune diseases excluding thyroid diseases

222

424

2.84

38.57

2.1

1.7

—

Autoimmune diseases excluding thyroid diseases, strict definition

216

408

2.88

38.54

2.1

1.7

—

Oedema, not elsewhere classified

214

4.40

38.25

1.9

1.7

—

Autoimmune diseases related-to ILD

200

600

2.79

38.12

2.1

1.7

—

Osteopathies and chondropathies

160

470

3.12

38.00

2.1

1.7

—

Nausea and vomiting

176

4.78

37.97

2.3

1.7

—

Erysipelas, including avohilmo

160

368

3.23

37.93

2.1

1.6

—

Fentanyl

7.10

36.72

1.9

1.8

—

Anaemias

11.08

36.72

2.0

1.6

—

Ulcerative colitis

160

4.96

36.70

2.2

1.9

—

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

192

452

2.87

36.45

1.8

1.7

—

Care involving dialysis

9.65

35.94

2.8

2.0

—

All chronic kidney diseases

147

363

3.24

35.79

2.3

1.6

—

All influenza

176

4.68

35.55

2.4

1.6

—

Gastrointestinal diseases

5.74

35.44

2.0

1.8

—

Tramadol

160

299

3.22

35.43

1.9

1.7

—

All kidney diseases

209

522

2.69

35.08

2.0

1.7

—

Benzodiazepine use

226

598

2.55

34.49

1.8

—

Headache

136

320

3.29

33.71

1.9

1.7

—

Caries of dentine

135

5.09

33.60

1.8

—

Acute tubulo-interstitial nephritis

159

459

2.93

33.31

2.1

1.6

—

General examination and investigation of persons without complaint and reported diagnosis

119

157

3.94

32.95

1.9

1.8

—

Opioids

182

322

2.92

32.72

2.0

1.7

—

Complications of procedures, not elsewhere classified

184

551

2.69

32.68

2.1

1.7

—

ILD medications: azathioprine

7.04

32.58

2.3

1.7

—

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

153

526

2.86

31.81

2.2

1.7

—

Mucosal proctocolitis

7.17

31.74

2.3

1.9

—

Renal failure

145

413

3.00

31.73

2.3

1.7

—

Aplastic and other anaemias

143

442

2.97

31.31

2.3

1.7

—

Amputation

6.22

31.27

2.1

1.7

—

238

493

2.45

30.75

2.0

1.7

—

Codeine

170

317

2.90

30.73

1.8

1.7

—

Crohn disease

6.71

30.53

2.2

2.1

—

Symptoms and signs involving the digestive system and abdomen

188

345

2.73

29.87

1.9

1.8

—

Malaise and fatigue

118

281

3.31

29.80

1.8

1.7

—

Noninfectious colitis NAS

6.02

29.76

2.1

2.0

—

Azathioprine

6.32

29.46

2.3

1.9

—

Collagenous colitis

7.05

29.23

1.9

2.0

—

Other special examinations and investigations of persons without complaint or reported diagnosis

115

158

3.69

29.07

1.9

1.8

—

Extracorporeal dialysis

9.09

28.62

3.1

1.8

—

Preparatory care for dialysis

10.17

28.32

3.1

1.7

—

Implicit viral Sepsis, including avohilmo

233

3.74

28.15

1.9

1.6

—

Dental caries

153

4.39

28.07

1.8

1.7

—

Other disorders of urethra and urinary system

160

409

2.73

28.05

2.0

1.8

—

Implicit viral Sepsis

145

4.57

27.91

2.0

1.5

—

Viral Sepsis

145

4.57

27.91

2.0

1.5

—

Constipation

195

537

2.46

27.80

1.8

—

Bronchitis

228

589

2.32

27.76

2.1

1.7

—

COPD (mode)

128

4.46

27.60

1.8

1.6

—

Examination and observation for other reasons

101

151

3.78

27.52

2.3

1.8

—

Iron deficiency anaemia

126

424

2.92

27.36

2.1

1.8

—

Follow-up examination after treatment for conditions other than malignant neoplasms

132

4.14

26.79

1.8

—

Autoimmune diseases

203

425

2.43

25.85

1.9

1.7

—

Other pulmonary diagnosis

127

201

3.17

25.83

2.1

1.7

—

Excluding asthma or asthma-COPD overlap

127

201

3.17

25.83

2.1

1.7

—

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

141

530

2.66

25.77

2.1

1.7

—

Abnormalities of breathing

172

384

2.57

25.42

2.0

1.8

—

Other anaemias

128

430

2.79

25.35

2.2

1.7

—

Osteoporosis

250

3.40

25.24

2.2

1.7

—

Used for control exclusion in common control thyroid runs

193

396

2.46

25.23

1.8

—

Dyspnoea

189

579

2.36

25.01

2.0

1.8

—

Other disorders of fluid, electrolyte and acid-base balance

273

3.29

24.97

2.0

1.7

—

Other and unspecified anaemias

126

426

2.78

24.82

2.3

1.7

—

Nutritional anaemias

136

488

2.66

24.70

2.1

1.7

—

Infections of the skin and subcutaneous tissue

127

459

2.73

24.35

2.3

1.7

—

Exposure to other specified factors

164

578

2.44

24.32

2.2

1.7

—

COPD differential diagnosis

125

205

3.06

24.10

2.0

1.7

—

ILD differential diagnosis

125

205

3.06

24.10

2.0

1.7

—

Ulcerative rectosigmoiditis

8.44

24.00

1.9

2.1

—

Fall on same level

207

480

2.30

23.93

1.7

1.8

—

Ulcerative colitis (strict definition, all Crohn cases excluded)

5.44

23.78

2.1

2.0

—

Abdominal and pelvic pain

173

345

2.52

23.75

1.8

—

Heart failure,strict

121

295

2.87

23.37

2.0

1.7

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

184

497

2.34

23.21

2.0

1.7

—

Retention of urine

230

3.24

22.76

1.9

—

Missing teeth due to accident, extraction or parodontitis

142

510

2.49

22.27

1.7

1.8

—

Liquid cancers

252

3.24

22.16

2.2

1.6

—

Crohn's disease NAS

8.56

21.90

2.2

—

Pain in joint

106

215

3.03

21.70

1.9

—

Obesity due to excess calories

103

363

2.84

21.51

2.0

1.8

—

Dysphagia

173

3.77

21.40

1.7

—

Acute upper respiratory infections

207

576

2.16

21.30

1.9

1.8

—

Other and unspecified iron deficiency

343

2.89

21.26

2.1

1.8

—

Substance abuse, excluding more controls

107

317

2.82

21.17

1.9

1.8

—

Other diseases of anus and rectum

216

3.42

21.10

1.7

1.8

—

Anxiety disorders, excluding more controls

151

395

2.44

21.02

2.0

1.8

—

Asthma, unspecified (mode)

193

3.26

21.02

2.0

1.7

—

Falls/tendency to fall

181

391

2.32

21.01

1.9

1.8

—

Liquid cancers, including Hilmo

286

2.97

21.00

2.1

1.6

—

Parasetamol

111

188

2.99

20.76

2.0

—

Depression or dysthymia

122

240

2.78

20.75

1.8

1.7

—

Syncope and collapse

262

3.00

20.70

1.6

1.7

—

Other disorders of skin and subcutaneous tissue

159

585

2.30

20.65

2.2

1.7

—

Asthma, unspecified (mode), excluding more controls

172

3.37

20.61

2.0

1.7

—

Other nutritional deficiencies

133

495

2.46

20.41

1.9

1.8

—

Diseases of the digestive system

117

449

2.59

20.41

2.1

1.8

—

Mood disorders, excluding more controls

169

430

2.31

20.40

1.7

1.8

—

Disorders of lens

129

307

2.61

20.32

2.0

1.8

—

Recurrent or chronic depression

134

3.68

20.28

1.8

—

All-cause Heart Failure

139

393

2.47

20.15

2.0

1.7

—

Early onset COPD, excluding more controls

4.95

20.09

1.8

1.7

—

Mental and behavioural disorders due to tobacco

6.58

20.01

1.7

2.2

—

Dialysis, with operation codes

5.03

19.94

2.8

1.9

—

Heart failure, strict

140

399

2.44

19.92

2.0

1.7

—

Polyuria

182

3.59

19.92

2.0

1.8

—

Diseases of the skin and subcutaneous tissue

179

396

2.27

19.83

1.9

1.7

—

Benign neoplasm of colon, rectum, anus and anal canal

145

523

2.35

19.82

2.0

1.7

—

Benign neoplasm: Colon

129

497

2.44

19.63

1.9

1.7

—

Chronic kidney disease

313

2.87

19.57

2.5

1.7

—

Acute renal failure

209

3.36

19.45

2.1

1.7

—

Primary_lymphoid and hematopoietic malignant neoplasms

224

3.27

19.42

2.3

1.8

—

Moderate visual impairment, binocular

8.48

19.30

1.9

1.8

—

Acute upper respiratory infections of multiple and unspecified sites

151

478

2.31

19.21

2.0

1.8

—

Supplementary factors related to causes of morbidity and mortality classified elsewhere

262

3.06

19.10

2.0

1.9

—

Persons encountering health services for examination and investigation

158

3.08

19.06

2.1

1.8

—

Polyarthropathies

130

335

2.50

18.97

1.9

1.8

—

Smoking dependency

6.20

18.91

1.7

2.1

—

Codeine or tramadol medication

205

538

2.07

18.67

1.8

—

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

147

568

2.26

18.47

2.1

1.7

—

Any mental disorder

188

438

2.15

18.41

1.8

—

Substance use, excluding alcohol

115

4.19

18.30

1.7

2.0

—

Persons encountering health services for specific procedures and health care

190

535

2.10

18.29

1.8

—

Other diseases of urinary system

175

451

2.18

18.28

1.9

1.8

—

Obesity and other hyperalimentation

124

487

2.40

18.20

2.0

1.8

—

Amputation of toe

5.63

18.20

2.1

1.7

—

Abnormal findings on diagnostic imaging of lung

117

452

2.46

18.15

2.2

1.7

—

Sleep apnoea

176

521

2.13

17.94

1.8

1.7

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

197

505

2.07

17.93

2.0

1.8

—

Metabolic disorders

173

482

2.16

17.90

1.9

1.8

—

Senile cataract

119

284

2.55

17.90

1.9

1.8

—

Other antidepressants

179

423

2.16

17.86

1.8

—

Non-invasive ventilation

4.32

17.85

2.0

1.7

—

Acute sinusitis

101

350

2.63

17.85

1.8

—

Obesity

123

487

2.38

17.81

2.0

1.8

—

Crohn's disease of small intestine

7.28

17.80

2.0

2.1

—

Diseases of arteries, arterioles and capillaries

147

482

2.24

17.54

1.9

1.7

—

Cellulitis

165

3.53

17.40

2.3

1.8

—

Use of hypnotics and sedatives

190

527

2.06

17.39

1.8

—

Sequelae of cerebrovascular disease

100

328

2.61

17.21

1.6

1.8

—

Decubitus ulcer and pressure area

6.23

17.20

2.4

1.8

—

Other external causes of accidental injury

128

259

2.48

17.16

2.0

1.9

—

Persons encountering health services in other circumstances, wide

203

517

2.02

17.11

1.8

—

Ulcer of lower limb, not elsewhere classified

130

3.87

17.10

2.5

1.8

—

Type of accident

248

2.99

17.03

2.0

1.8

—

Chronic laryngitis and laryngotracheitis

113

4.09

17.00

1.7

2.0

—

Other abnormal uterine and vaginal bleeding

116

3.67

16.99

1.5

2.0

—

Second line medication for Crohn's disease

115

482

2.39

16.97

2.0

1.7

—

Accidents

127

259

2.46

16.77

2.0

1.9

—

Neurotic, stress-related and somatoform disorders

158

509

2.14

16.67

2.0

1.8

—

Implicit fungal Sepsis, including avohilmo

6.71

16.57

2.0

1.6

—

Fitting and adjustment of other devices

311

2.64

16.50

1.7

—

Glomerular diseases

143

3.65

16.43

2.8

1.7

—

Follow-up care involving plastic surgery

14.43

16.33

1.3

2.2

—

Candidiasis, including avohilmo

256

2.90

16.12

2.0

1.8

—

Vocal cord dysfunction

6.09

16.11

1.6

2.0

—

Symptoms and signs involving the skin and subcutaneous tissue

140

616

2.15

15.96

1.9

1.8

—

Peripheral artery operations in Hilmo

123

3.84

15.94

2.1

1.7

—

Acute bronchitis

392

2.48

15.87

2.2

1.8

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

126

3.77

15.86

1.8

1.9

—

Other soft tissue disorders, not elsewhere classified

159

425

2.13

15.83

1.8

—

Bleeding

159

535

2.09

15.81

1.9

1.8

—

Peripheral artery disease

111

366

2.40

15.81

2.1

1.7

—

Anxiety disorders

158

519

2.09

15.72

2.0

1.8

—

Depression

169

555

2.04

15.64

1.7

1.8

—

Visual impairment including blindness (binocular or monocular)

5.30

15.60

1.9

2.0

—

Low back pain

138

424

2.20

15.53

1.8

1.9

—

Iron deficiency anaemia secondary to blood loss (chronic)

144

3.56

15.52

2.3

1.9

—

Diseases of the respiratory system

174

2.74

15.43

2.2

1.6

—

Asthma (only as main-diagnosis), excluding more controls

178

2.77

15.22

2.2

1.7

—

Nephropathy related operations

4.34

15.19

3.0

2.0

—

Viral pneumonia

4.42

15.16

2.0

1.7

—

Sleep apnoea, including avohilmo

177

537

1.99

15.12

1.8

—

Chronic gastritis

233

2.93

15.10

1.8

1.7

—

Other acute lower respiratory infections

114

477

2.28

15.06

2.2

1.7

—

Diseases of arteries, arterioles and capillaries (FINNGEN)

3.75

15.01

2.4

1.8

—

Other medical care

106

375

2.38

15.00

1.8

1.7

—

Exposure to unspecified factor

182

636

1.95

14.95

2.0

1.8

—

Dipeptidyl peptidase 4 (DPP-4) inhibitors

125

442

2.22

14.93

2.0

1.7

—

Familial hypercholesterolemia

134

3.60

14.87

2.2

1.8

—

Nerve, nerve root and plexus disorders

193

603

1.92

14.87

1.7

1.9

—

Glomerular disorders in diseases classified elsewhere

4.25

14.77

2.8

1.9

—

Sleep disorders (combined)

194

523

1.94

14.77

1.8

—

Polycystic ovarian syndrome, consortium definition

129

329

2.25

14.74

1.8

—

Cystitis

150

425

2.10

14.65

1.8

—

Disorders of gallbladder, biliary tract and pancreas

178

566

1.96

14.57

1.9

1.8

—

Myalgia

170

3.24

14.56

1.9

—

Mood [affective] disorders

179

589

1.95

14.53

1.8

—

Presence of other functional implants

121

368

2.25

14.52

2.1

1.6

—

Pain associated with micturition

4.27

14.51

1.6

1.8

—

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

109

3.87

14.44

1.7

1.8

—

COPD, hospital admission 2, with asthma infections

289

2.57

14.43

1.8

—

Asthma (only as main-diagnosis)

199

2.61

14.42

2.2

1.7

—

Mood disorders

179

590

1.94

14.39

1.8

—

Fissure and fistula of anal and rectal regions

142

3.46

14.35

2.2

1.9

—

Soft tissue disorders

169

429

2.02

14.32

1.8

—

Other diseases of the digestive system

319

2.58

14.32

2.2

1.8

—

Substance abuse

107

434

2.29

14.30

1.9

—

All influenza (not pneumonia)

4.30

14.25

2.1

1.6

—

Selective serotonin reuptake inhibitors

165

423

2.03

14.24

1.8

—

Symptoms and signs involving cognition, perception, emotional state and behaviour

170

583

1.95

13.99

1.9

1.8

—

Impingement syndrome of shoulder

170

3.19

13.89

1.8

—

Pain in throat and chest

136

377

2.14

13.88

1.7

1.8

—

Psychiatric diseases

157

383

2.05

13.86

1.8

—

Inflammatory diseases of female pelvic organs

116

355

2.24

13.73

1.6

1.8

—

Benign neoplasms

161

437

2.01

13.67

1.8

1.9

—

Anxiety (asthma-related co-morbidities)

101

328

2.34

13.61

2.1

1.8

—

Heart failure and bmi 25plus

252

2.47

13.53

2.0

1.7

—

Hypertensive heart and/or renal disease

174

2.86

13.46

1.8

—

Disorders of other endocrine glands

390

2.35

13.34

2.1

1.7

—

COPD, hospital admissions 3, with asthma pneumonia sepsis

254

2.61

13.32

1.8

—

L04AX Other immunosuppressants

105

472

2.23

13.31

2.0

1.7

—

Hypothyroidism, strict autoimmune

120

361

2.18

13.27

1.9

1.7

—

Non-selective monoamine reuptake inhibitors

294

2.55

13.27

1.9

1.7

—

Unspecified fall

108

483

2.20

13.22

2.1

1.7

—

Mental and behavioural disorders due to psychoactive substance use

107

443

2.21

13.18

1.9

—

Thrombocytopenia, unspecified

5.13

13.15

2.0

—

Neurological diseases

125

286

2.20

13.05

1.8

1.9

—

Factors influencing health status and contact with health services

4.24

13.04

2.1

1.8

—

Unspecified haematuria

286

2.45

13.02

1.7

1.9

—

Paralytic ileus and intestinal obstruction

183

3.01

12.89

2.2

1.8

—

Mycoses, including avohilmo

159

632

1.92

12.85

2.0

1.8

—

Other female pelvic inflammatory diseases

114

3.61

12.82

1.5

1.8

—

Other diseases of oesophagus

4.70

12.81

2.3

1.7

—

Intracranial trauma

226

2.51

12.78

1.6

2.0

—

Dermatitis and eczema

192

622

1.83

12.74

1.9

1.8

—

Menorrhagia

134

2.88

12.73

1.6

2.0

—

Other specific joint derangements/joint disorders

118

339

2.17

12.73

1.9

1.8

—

Lower back pain or/and sciatica

185

627

1.83

12.56

1.7

1.9

—

All anxiety disorders

102

353

2.24

12.56

2.1

1.8

—

Mycoses

241

2.70

12.54

2.5

1.8

—

Dorsalgia

160

435

1.95

12.52

1.7

1.9

—

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

6.21

12.46

1.9

2.2

—

Candidiasis

107

3.66

12.44

2.3

1.9

—

Faecal incontinence

4.69

12.34

2.0

1.7

—

Secondary hypertension

5.88

12.33

2.5

1.9

—

Other anxiety disorders

262

2.50

12.32

2.0

1.8

—

Leisure time condition

142

3.25

12.27

2.0

1.9

—

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

6.46

12.24

2.1

1.7

—

Open wound of head

107

470

2.14

12.21

1.9

1.8

—

Episodal and paroxysmal disorders

174

469

1.88

12.18

1.8

1.9

—

Atherosclerosis, excluding cerebral and coronary sclerosis

348

2.24

12.16

2.1

1.7

—

Other chronic obstructive pulmonary disease, including avohilmo

112

436

2.11

12.04

1.7

1.8

—

L04AA Selective immunosuppressants

160

3.07

11.92

2.5

1.9

—

Convulsions, not elsewhere classified

123

3.38

11.89

1.9

1.8

—

Other CVD (FINNGEN)

4.48

11.84

1.8

—

COPD

365

2.21

11.84

1.7

—

Asthma, excluding more controls

178

2.48

11.82

2.1

1.7

—

Cerebrovascular diseases (FINNGEN)

110

3.19

11.78

1.9

1.8

—

Other and unspecified polyneuropathies, also in other diseases

177

2.95

11.78

2.1

1.8

—

Symptoms and signs involving the circulatory and respiratory systems

150

384

1.96

11.75

2.0

1.8

—

Dizziness and giddiness

135

539

1.95

11.57

1.9

1.8

—

Injuries to the head

186

618

1.79

11.52

1.7

1.8

—

Other cataract

265

2.36

11.51

1.8

—

Genitourinary diseases

141

2.63

11.34

2.1

1.8

—

Asthma

199

2.36

11.31

2.2

1.7

—

Pain in limb

131

420

1.98

11.30

1.9

1.8

—

Chronic ulcer of skin, not elsewhere classified

4.75

11.17

1.9

—

GI-bleeding

322

2.37

11.16

2.2

1.8

—

Heart failure and antihypertensive medication

3.25

11.16

2.2

1.8

—

Other dialysis

12.86

11.16

4.0

1.6

—

Undetermined asthma, excluding more controls

4.57

11.14

2.4

1.6

—

External causes of morbidity and mortality

191

2.36

11.13

2.1

1.9

—

Polyneuropathies and other disorders of the peripheral nervous system

205

2.74

11.13

2.1

1.8

—

Pure hypercholesterolaemia

130

418

1.98

11.11

1.9

1.7

—

Injuries to the thorax

443

2.15

11.09

2.2

1.7

—

Concussion

226

2.47

11.04

1.8

2.0

—

Diabetes, insulin treatment (Kela reimbursement)

173

572

1.80

11.03

1.8

—

Coagulation defects, purpura and other haemorrhagic conditions

157

3.00

11.02

2.1

1.9

—

Injuries to the shoulder and upper arm

150

627

1.85

10.95

1.9

1.8

—

Other and unspecified myopathies

3.83

10.91

2.1

2.0

—

Other reaction to severe stress, and adjustment disorders

224

2.64

10.90

2.2

1.8

—

Visual disturbances and blindness

103

500

2.06

10.83

1.7

—

COPD-related respiratory insufficiency

123

3.27

10.78

2.0

1.9

—

Cerebrovascular diseases

137

499

1.91

10.77

1.8

—

Donors of organs and tissues

28.59

10.76

1.9

2.8

—

Carpal tunnel syndrome

111

478

2.01

10.69

1.7

1.8

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

160

520

1.83

10.68

1.9

1.8

—

Purpura and other haemorrhagic conditions

104

3.48

10.68

2.1

1.9

—

Spondylopathies

132

401

1.95

10.67

1.8

1.9

—

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

4.04

10.67

2.1

1.7

—

Generalized anxiety disorder

4.03

10.63

1.9

2.0

—

Diabetes mellitus

169

544

1.79

10.61

1.9

1.8

—

Hypertensive Heart Disease

167

2.69

10.61

1.8

—

Later onset COPD, excluding more controls

3.27

10.60

1.7

1.6

—

Cholelithiasis, broad definition with cholecystitis

151

547

1.84

10.57

1.8

—

Other chronic obstructive pulmonary disease

354

2.15

10.56

1.7

—

Enlarged lymph nodes

3.73

10.55

1.8

—

Transport accidents

235

2.45

10.54

2.2

1.9

—

Injuries to the abdomen, lower back, lumbar spine and pelvis

401

2.17

10.51

2.0

1.8

—

Disorder of lipoprotein metabolism, unspecified

115

3.32

10.51

1.9

1.8

—

Polyarthrosis

163

2.83

10.50

1.8

—

Hyperkalaemia

4.65

10.47

2.4

1.7

—

Other diseases of blood and blood-forming organs, wide

190

2.75

10.40

2.0

1.9

—

6-mercaptopurine

16.15

10.35

1.9

2.2

—

Obesity, other/unspecified

248

2.50

10.35

2.0

1.9

—

Peripheral arterial reconstruction

180

2.79

10.28

2.3

1.8

—

Ventral hernia

214

2.62

10.27

2.2

1.9

—

Undetermined asthma

4.27

10.27

2.4

1.6

—

Streptococcal septicaemia

4.91

10.25

2.6

1.5

—

Streptococcal septicaemia, including avohilmo

4.91

10.25

2.6

1.5

—

Diabetes, varying definitions

167

544

1.78

10.25

1.9

1.8

—

Osteomyelitis

4.73

10.24

1.8

1.9

—

Finngen Rheumatological endpoints

145

442

1.86

10.21

1.8

—

Diseases of inner ear

108

521

1.99

10.20

1.6

1.7

—

Cholelithiasis

146

544

1.83

10.19

1.8

—

Chronic pancreatitis

3.56

10.18

2.0

—

Other Crohn's disease

7.47

10.16

2.1

—

Diseases of external ear

330

2.28

10.15

1.8

—

Persons encountering health services in other circumstances

308

2.32

10.12

2.0

1.7

—

Hypo-osmolality and hyponatraemia

164

2.85

10.08

1.8

1.7

—

Insulin medication

111

467

1.97

10.06

2.3

1.8

—

Disorders of lacrimal system

427

2.10

10.05

1.6

1.7

—

Diabetes medication

172

575

1.75

9.95

1.8

—

COPD, early/later onset

384

2.08

9.94

1.7

1.8

—

Hernia

159

596

1.77

9.94

1.8

—

Shoulder lesions

123

380

1.94

9.92

1.5

1.8

—

Insulin, intermediate and long-acting

102

492

2.00

9.90

2.2

1.7

—

Other intervertebral disc disorders

132

416

1.89

9.89

1.6

1.9

—

Injuries to the hip and thigh

103

462

2.00

9.85

2.2

1.7

—

Type 2 diabetes, wide definition

139

474

1.85

9.85

1.8

—

Disorders of vestibular function (Vertigo)

459

2.04

9.82

1.6

1.7

—

Ulcerative enterocolitis

10.72

9.79

2.7

1.8

—

Intestinal adhesions without obstruction

4.90

9.78

1.9

1.7

—

Type 2 diabetes

162

530

1.77

9.77

1.8

—

Gastric ulcer

152

2.90

9.77

2.0

1.7

—

Other systemic involvement of connective tissue (FG)

221

2.54

9.75

1.7

—

Disorders of eyelid, lacrimal system and orbit

151

622

1.78

9.75

1.8

—

Respiratory insufficiency

4.69

9.71

1.7

1.6

—

Other dorsopathies, not elsewhere classified

152

435

1.82

9.70

1.7

1.9

—

Mental and behavioural disorders due to alcohol, excluding acute intoxication

346

2.21

9.70

1.9

—

COPD, hospital admissions

384

2.07

9.68

1.7

1.8

—

Alcohol use disorder, Swedish definition

405

2.07

9.64

1.9

—

Benign neoplasm: Colon, unspecified

245

2.46

9.63

2.0

1.8

—

Other/unspecified dorsalgia

315

2.26

9.59

1.8

—

Functional dyspepsia

193

2.65

9.56

2.0

1.6

—

Biological medication for rheuma

102

3.34

9.55

2.1

2.0

—

Agranulocytosis

3.63

9.52

1.9

2.0

—

Gastroduodenal ulcer

222

2.52

9.49

1.9

1.8

—

Pain (limb, back, neck, head abdominally)

100

239

2.10

9.49

1.9

—

Neurological diseases, wide definition

4.12

9.49

1.7

1.8

—

Explicit bacterial Sepsis

4.01

9.49

2.5

1.6

—

Primary gonarthrosis, bilateral

106

454

1.96

9.42

1.8

—

Fracture of lumbar spine and pelvis

235

2.47

9.41

2.2

1.8

—

Pain, not elsewhere classified

161

2.80

9.39

1.7

1.8

—

Internal derangement of knee

270

2.35

9.33

2.0

1.8

—

Other ulcerative colitis

8.06

9.33

2.2

2.1

—

Diseases of the myoneural junction and muscle

109

3.23

9.28

2.0

1.9

—

Hypertensive diseases (excluding secondary)

164

2.41

9.28

1.9

1.8

—

Disorders of lipoprotein metabolism and other lipidaemias

133

439

1.84

9.26

1.9

1.8

—

Insulin, fast-acting

299

2.28

9.24

2.4

1.8

—

Haemorrhoids and perianal venous thrombosis

230

2.46

9.23

1.6

1.8

—

Other disorders of lacrimal gland

338

2.19

9.20

1.6

1.8

—

Hypertension, essential

113

327

1.95

9.20

2.0

1.8

—

Non-ischemic cardiomyopathy

243

2.29

9.19

1.7

1.8

—

Disorders of parathyroid gland

212

2.53

9.18

2.0

1.8

—

Non-Hodgkin lymphoma, all, including Hilmo

110

3.19

9.15

2.1

1.8

—

Haemorrhage from respiratory passages

258

2.30

9.13

2.1

1.8

—

Explicit bacterial Sepsis, including avohilmo

3.89

9.12

2.5

1.6

—

Endocrine, nutritional and metabolic diseases

108

273

2.00

9.08

2.0

1.8

—

Insulin, combination of fast acting with intermediate-acting or long-acting

111

534

1.89

9.01

2.3

1.7

—

Presence of cardiac and vascular implants and grafts

297

2.11

9.01

1.8

1.6

—

Depression medications

4.29

9.01

2.0

1.6

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

182

2.64

8.98

1.7

2.0

—

Other diseases of pleura

404

2.00

8.91

1.9

1.8

—

Injuries to the ankle and foot

111

503

1.89

8.91

2.1

1.8

—

COPD related to multimorbidity

347

2.07

8.89

1.7

1.8

—

Diseases of the ear and mastoid process

170

498

1.71

8.88

1.9

1.8

—

Other and unspecified local infections of skin and subcutaneous tissue

3.92

8.85

2.1

2.0

—

Other diseases of stomach and duodenum

4.68

8.82

1.6

1.7

—

Amputation of foot

8.71

8.82

2.2

2.1

—

Other diseases of lip and oral mucosa

377

2.10

8.81

1.7

—

Fungal Sepsis

8.65

8.80

1.9

1.8

—

Injury, poisoning and certain other consequences of external causes

161

2.31

8.79

2.1

1.9

—

Volume depletion

3.51

8.78

2.5

1.7

—

Other (not insulin) diabetes medications

161

552

1.71

8.75

1.8

—

Suicide or other Intentional self-harm

162

2.72

8.73

1.6

2.0

—

Asthma (mode)

205

2.15

8.66

2.1

1.7

—

Other heart diseases, wide

128

425

1.82

8.65

1.9

1.8

—

Secondary uncertain malignant neoplasm

114

3.08

8.65

1.9

1.8

—

Sulfasalazine

180

2.62

8.64

2.1

1.7

—

Crohn's disease of large intestine

7.66

8.64

2.3

1.8

—

Other local infections of skin and subcutaneous tissue

3.73

8.60

2.1

2.0

—

therapeutic use

9.06

8.54

1.9

1.8

—

Injuries to the knee and lower leg

185

608

1.65

8.53

1.8

—

Diseases of salivary glands

285

2.25

8.50

1.7

1.8

—

Alcohol use disorder, ICD-based

317

2.18

8.49

1.9

—

Abnormalities of heart beat

276

2.25

8.47

1.8

1.7

—

Venous thromboembolism

106

547

1.87

8.46

2.3

1.7

—

Other or unspecified ileus, impaction or obstruction

132

2.88

8.40

2.2

1.8

—

Acetic acid derivatives and related substances

2.79

8.35

2.1

1.9

—

Neoplasms

247

2.02

8.33

1.9

1.8

—

Familial hypercholesterolemia, with ischemic heart disease

3.31

8.33

2.5

1.9

—

Personal history of other diseases and conditions

4.28

8.32

2.2

1.7

—

Implicit fungal Sepsis

8.58

8.31

2.0

1.8

—

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.63

8.27

3.0

2.0

—

Urinary track infection

209

2.09

8.21

1.9

1.7

—

Viral and other specified intestinal infections, including avohilmo

139

2.77

8.18

1.7

—

Otitis externa

180

2.56

8.12

1.8

1.9

—

Sciatica+with lumbago

366

2.01

8.11

1.7

1.8

—

Diseases of peritoneum

3.48

8.08

2.5

2.0

—

Trochanteric bursitis

103

3.12

8.08

2.0

1.9

—

Other joint disorders

126

363

1.81

8.08

1.7

1.8

—

Orthopaedic devices associated with adverse incidents

9.08

8.07

1.9

1.7

—

Fibrosis and cirrhosis of liver

3.77

8.06

2.0

—

Other skin changes

175

2.58

8.05

1.5

1.8

—

Intestinal stricture

318

2.14

8.03

2.1

1.7

—

Cutaneous abscess, furuncle and carbuncle

193

2.49

8.02

2.6

1.8

—

Superficial injury of lower leg

193

2.49

8.02

2.0

1.8

—

Polymyalgia rheumatica

136

2.81

7.99

1.6

1.8

—

Fibromyalgia

4.13

7.98

1.5

1.9

—

Other disorders of bone

125

2.89

7.98

1.9

1.8

—

Dental operations

105

282

1.92

7.96

1.8

1.9

—

Insulin, fast-acting or short human

319

2.13

7.96

2.4

1.8

—

FESS (DNB20)

3.53

7.95

1.7

2.0

—

Other respiratory disorders and diseases

212

2.41

7.95

1.7

1.8

—

Other diseases of the respiratory system

212

2.41

7.95

1.7

1.8

—

STROKE

293

2.00

7.95

1.7

—

Other diseases of upper respiratory tract

169

533

1.65

7.90

1.8

—

Heartburn

3.70

7.89

2.0

1.8

—

Persistent mood disorders

137

2.78

7.88

2.0

1.9

—

Localized swelling, mass and lump of skin and subcutaneous tissue

269

2.23

7.87

2.1

1.8

—

Chronic sinusitis

327

2.11

7.85

1.8

—

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

3.17

7.79

1.7

2.0

—

Diaphragmatic hernia

342

2.08

7.78

1.8

—

Other systemic involvement of connective tissue

264

2.24

7.78

1.7

1.8

—

Amputation of thigh

7.00

7.78

2.1

1.9

—

Type 1 diabetes

178

2.53

7.76

2.3

1.8

—

Chronic diseases of tonsils and adenoids

108

369

1.85

7.72

2.0

1.8

—

427

1.90

7.66

1.9

—

Somatoform disorder

112

2.95

7.63

1.7

1.9

—

Systemic connective tissue disorders

345

2.06

7.62

1.9

1.8

—

Other viral diseases, including avohilmo

245

2.27

7.60

2.5

1.8

—

Symptoms and signs concerning food and fluid intake

3.71

7.59

1.8

1.9

—

Any reimbursement code in KELA

140

2.29

7.57

2.0

1.5

—

Stroke, excluding SAH

111

445

1.80

7.56

1.6

1.8

—

Colonic or urogenital fistula

236

2.29

7.54

2.2

1.8

—

436

1.88

7.54

1.9

—

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

199

2.39

7.48

1.7

—

Excessive, frequent and irregular menstruation

138

2.32

7.45

1.7

2.0

—

Viral infections characterized by skin and mucous membrane lesions

369

2.01

7.39

2.1

1.8

—

Other diseases of arteries and capillaries

3.44

7.38

1.7

1.8

—

Crohn disease (strict definition, require KELA, min 2 HDR)

5.97

7.37

1.9

—

Crohn disease (strict definition, require KELA)

5.97

7.37

1.9

—

DVT of lower extremities and pulmonary embolism

444

1.91

7.35

2.4

1.7

—

Complications of internal orthopaedic prosthetic devices, implants and grafts

208

2.36

7.32

1.9

1.7

—

Coxibs

2.66

7.25

1.7

1.9

—

Rheumatism, unspecified

3.16

7.24

1.5

1.8

—

Non-follicular lymphoma

3.23

7.24

1.9

2.0

—

Other viral diseases

190

2.42

7.23

2.6

1.8

—

Convalescence

5.80

7.21

1.4

1.9

—

Hypertensive diseases

107

331

1.82

7.21

2.0

1.8

—

Hypertension

107

331

1.82

7.21

2.0

1.8

—

Cough

290

2.09

7.20

1.8

1.7

—

Disorders resulting from impaired renal tubular function

7.34

7.19

3.2

1.9

—

Multiple myeloma, including Hilmo

4.51

7.18

2.0

1.9

—

Other follicular disorders

4.49

7.17

1.9

—

Gout

221

2.22

7.16

2.5

1.8

—

Stroke, including SAH

112

456

1.76

7.13

1.6

1.8

—

Pulmonary heart disease, diseases of pulmonary circulation

334

2.04

7.11

2.5

1.8

—

Ethmoidectomy

3.26

7.09

1.7

2.0

—

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

381

1.95

7.08

2.0

1.8

—

Impacted cerumen

101

2.98

7.06

1.8

2.0

—

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

123

2.77

7.04

2.1

1.9

—

Vasomotor and allergic rhinitis

244

2.20

7.01

1.8

—

Arthropathies in other diseases classified elsewhere

7.02

7.00

1.6

1.9

—

Dialysis

7.01

7.00

3.1

1.9

—

Type 2 diabetes, definitions combined, including avohilmo

145

508

1.65

6.98

1.8

—

Other peripheral vertigo

3.39

6.96

1.8

2.1

—

Other heart diseases

161

2.26

6.95

2.1

1.8

—

Poisoning by drugs, medicaments and biological substances

153

2.55

6.91

1.9

—

Fenamates

3.19

6.90

1.8

2.0

—

Pain and other conditions associated with female genital organs and menstrual cycle

2.85

6.90

1.5

2.0

—

Unspecified kidney failure

3.06

6.88

2.5

1.7

—

Chronic apical periodontitis

168

594

1.59

6.87

1.7

1.8

—

Anaemia in chronic diseases classified elsewhere

8.34

6.84

2.6

1.8

—

Other headache syndromes

318

2.04

6.82

1.6

1.8

—

Mental and behavioural disorders due to alcohol

388

1.92

6.81

1.9

—

Hyperparathyroidism

182

2.40

6.80

2.1

1.7

—

Chondropathies

2.97

6.79

2.0

2.1

—

Organic, including symptomatic, mental disorders

102

402

1.79

6.78

1.6

1.8

—

Dermatitis

547

1.77

6.77

2.1

1.8

—

Ulcerative proctitis

6.10

6.76

2.1

—

Dorsopathies

142

435

1.65

6.70

1.7

1.9

—

Pulmonary embolism

302

2.06

6.66

2.5

1.8

—

Total colectomy operation

6.45

6.64

2.7

1.8

—

Total colectomy

6.45

6.64

2.7

1.8

—

Status post-ami

205

2.15

6.62

2.1

1.9

—

Type 2 diabetes, definitions combined

145

519

1.63

6.62

1.8

—

Acute posthaemorrhagic anaemia

5.92

6.61

3.0

1.9

—

Pulmonary heart disease

303

2.05

6.61

2.5

1.8

—

Diffuse large B-cell lymphoma

4.17

6.55

1.9

2.0

—

Diffuse large B-cell lymphoma, helper endpoint

4.17

6.55

1.9

2.0

—

Diffuse large B-cell lymphoma, including Hilmo

4.17

6.55

1.9

2.0

—

Fibroblastic disorders

194

2.32

6.53

1.7

1.8

—

Type 2 diabetes, strict (exclude DM1)

145

521

1.62

6.53

1.8

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

147

579

1.60

6.49

2.1

1.8

—

Bipolar affective disorders

101

2.88

6.45

2.0

—

COPD, hospital admissions 1, only main diagnosis

313

1.95

6.45

1.7

1.8

—

Alcohol withdrawal state with delirium

3.93

6.43

1.9

2.2

—

Acute gastritis

3.93

6.43

1.4

1.7

—

Diabetic nephropathy, excluding more controls

103

2.70

6.41

2.8

1.6

—

Ischaemic Stroke, excluding all haemorrhages

104

441

1.74

6.37

1.7

1.8

—

Cirrhosis of liver, NAS

4.07

6.35

2.0

—

Other otitis externa (chronic)

4.07

6.35

1.3

2.0

—

Diseases of liver

308

2.02

6.34

2.0

1.8

—

Special screening examination for neoplasms

6.55

6.33

1.7

—

Any event in cancer register

128

451

1.66

6.33

2.0

1.7

—

Open wound of wrist and hand

337

1.95

6.31

2.2

1.8

—

Gout, FINNGEN

273

2.08

6.31

2.5

1.8

—

Charcot foot

9.37

6.30

1.3

1.8

—

Early onset COPD

185

2.33

6.29

1.8

1.9

—

Disturbances of skin sensation

185

2.33

6.29

1.8

1.9

—

Type 1 diabetes, wide definition, subgroup 1

131

2.60

6.26

2.0

1.9

—

Biguanides

148

562

1.59

6.26

1.7

1.8

—

Soft tissue disorders related to use, overuse and pressure

217

2.22

6.26

1.9

1.8

—

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

136

660

1.60

6.25

2.0

1.8

—

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

246

2.13

6.25

2.2

1.9

—

Other CVD

224

2.19

6.22

2.1

1.8

—

Conduction disorders

197

2.16

6.21

1.9

1.8

—

Tumor necrosis factor alpha inhibitors

3.00

6.21

2.3

2.0

—

Cardiac arrhythmias

232

1.96

6.19

1.9

1.8

—

Conjunctivitis (acute, non atopic)

217

2.21

6.19

1.9

—

Panic disorder

3.20

6.13

2.1

2.0

—

Benign paroxysmal vertigo

285

2.04

6.13

1.6

1.8

—

Hypothyroidism, other/unspecified

137

562

1.60

6.10

1.8

—

Other benign neoplasms of skin

369

1.90

6.06

1.6

1.8

—

Hernia of abdominal wall

419

1.84

6.04

2.1

1.8

—

Hypokalaemia

2.88

6.03

2.0

1.8

—

Heart failure and coronary heart disease

338

1.80

6.02

2.1

1.8

—

Caries of dentine, including avohilmo

122

374

1.67

6.01

1.8

—

Alcoholic liver disease

3.16

6.01

1.7

1.9

—

Elevated blood glucose level

3.35

5.99

1.8

2.1

—

Crohn disease (strict definition, all UC cases excluded)

5.55

5.99

2.0

2.2

—

Type 1 diabetes, wide definition

146

2.47

5.98

2.0

1.9

—

Paracetamol or NSAID medication

3.93

5.98

2.1

1.7

—

Urticaria and erythema

288

2.02

5.96

2.0

1.8

—

Arthropathies

120

363

1.67

5.94

1.8

—

Rotator cuff syndrome

354

1.77

5.91

1.8

—

Diseases of pulp and periapical tissues and dental caries

107

319

1.72

5.91

1.9

1.8

—

Other specified/unspecified arthritis

210

2.19

5.88

2.0

1.8

—

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

3.53

5.87

1.9

1.8

—

Plantar fascial fibromatosis

3.53

5.87

1.8

2.1

—

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

6.43

5.87

1.9

—

Multiple myeloma

6.43

5.87

1.9

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

140

581

1.58

5.87

1.8

—

Fracture of rib(s), sternum and thoracic spine

290

2.00

5.86

2.3

1.7

—

Propionic acid derivatives

2.43

5.85

2.1

1.9

—

Other disorders of kidney and ureter

113

2.66

5.81

2.5

1.9

—

Rheumatoid arthritis

238

2.05

5.78

1.7

1.8

—

Enthesopathies of lower limb, excluding foot

180

2.28

5.76

1.5

1.8

—

Cardiovascular diseases (excluding rheumatic etc)

199

1.96

5.74

1.9

—

Diseases of pulp and periapical tissues, including avohilmo

155

517

1.55

5.74

1.8

—

L04AD Calcineurin inhibitors

3.15

5.73

3.7

2.0

—

Disorders of mineral metabolism

3.47

5.72

1.4

1.8

—

Mental and behavioural disorders due to sedatives or hypnotics

5.18

5.69

1.7

2.1

—

Other and unspecified nerve root and plexus disorders, also in other diseases

156

2.38

5.69

1.7

2.0

—

Haemorrhage, not elsewhere classified

6.13

5.69

2.3

1.7

—

Attention to artificial openings

6.13

5.69

1.5

2.0

—

Fracture of femur

294

1.93

5.67

2.0

1.8

—

Poisoning by medicine

138

2.47

5.67

1.9

2.0

—

Oter anti-inflammatory and antirheumatic agents, non-steroids

2.54

5.66

1.7

1.9

—

Cytomegalovirus infection, IBD co-morbidity

7.59

5.64

3.3

1.9

—

Cytomegaloviral disease

7.58

5.64

3.3

2.1

—

Cytomegaloviral disease, including avohilmo

7.58

5.64

3.3

2.1

—

Hypotension

201

2.19

5.63

1.7

1.8

—

Disorders of choroid and retina

129

569

1.59

5.62

1.8

—

Benign neoplasm: Sigmoid colon

182

2.26

5.62

1.9

1.8

—

Presence of other devices

230

2.10

5.61

1.6

—

Stomatitis and related lesions

151

2.39

5.60

2.0

—

Other symptoms and signs involving the circulatory and respiratory systems

4.74

5.60

2.3

1.8

—

Psoriatic and enteropathic arthropathies

3.19

5.58

1.8

2.1

—

Diseases of the eye and adnexa

257

1.77

5.57

2.0

1.9

—

Hepatic failure, not elsewhere classified

5.40

5.54

1.7

1.9

—

Hypothyroidism (congenital or acquired)

3.56

5.53

1.7

—

Intracranial injury

504

1.70

5.52

1.8

—

Cholecystectomy

116

614

1.61

5.48

1.8

—

Infections with a predominantly sexual mode of transmission

184

2.23

5.45

1.9

—

Gluteal tendinitis

4.88

5.43

1.7

2.0

—

Diabetic neuropathy

111

2.61

5.41

2.1

1.9

—

Other symptoms and signs involving cognitive functions and awareness

422

1.74

5.41

1.7

1.8

—

Other arthritis (FG)

258

2.02

5.40

1.9

1.7

—

Other arrhythmias

375

1.73

5.38

1.6

1.8

—

Migraine

262

1.90

5.37

1.7

1.9

—

Other specified/unspecified bacterial intestinal infections

3.74

5.36

1.6

1.7

—

Alcohol dependence

199

2.16

5.35

2.0

1.8

—

ILD, hospital admission 2, with pulmonary infections

3.10

5.33

2.2

1.6

—

Multiple myeloma and malignant plasma cell neoplasms

3.56

5.33

2.0

1.8

—

Allergic rhinitis

184

2.20

5.31

1.7

2.0

—

Failure and rejection of transplanted organs and tissues

11.42

5.30

5.7

1.9

—

Pneumonitis due to solids and liquids

2.92

5.29

1.9

—

Zoster [herpes zoster]

187

2.20

5.29

2.1

1.8

—

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

168

2.27

5.28

1.7

1.6

—

Diseases of oral cavity, salivary glands and jaws

266

1.74

5.26

1.8

1.9

—

Migraine without aura

2.71

5.25

1.7

2.0

—

Alcohol abuse, main dg, excluding more controls

2.98

5.24

2.0

1.9

—

Diabetic retinopathy, strict definition

137

2.34

5.24

1.8

—

Other retinal disorders

111

524

1.61

5.24

1.8

—

Subjective visual disturbances

214

2.11

5.24

1.7

1.9

—

Psychotic depression

5.93

5.21

1.6

1.5

—

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

221

2.08

5.21

1.9

1.8

—

Glucagon-like peptide-1 (GLP-1) analogues

221

2.08

5.21

1.9

1.8

—

Other sleep disorders

3.05

5.21

2.2

2.1

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

151

2.09

5.18

2.3

1.8

—

Acute suppurative otitis media

128

2.41

5.17

1.8

1.9

—

Personality disorders, excluding more controls

114

2.54

5.16

2.2

2.0

—

Hypothyroidism, levothyroxine purchases

3.50

5.16

1.8

1.7

—

Hypothyroidism and >3 levothyroxin purchases

3.50

5.16

1.8

1.7

—

Paralytic ileus

7.38

5.14

2.2

1.9

—

Pruritus

2.80

5.13

2.1

1.8

—

Malignant neoplasm

116

424

1.60

5.12

2.0

1.6

—

Diseases of the musculoskeletal system and connective tissue

145

2.01

5.12

1.9

—

Malignant neoplasm

116

424

1.60

5.12

2.0

1.6

—

Other disorders of the genitourinary system

109

2.58

5.12

1.5

1.9

—

Sensorineural hearing loss

121

512

1.58

5.11

2.0

1.8

—

Nonorganic sleeping disorders, excluding more controls

109

2.57

5.11

2.0

1.8

—

Superficial injury of thorax

121

2.49

5.10

2.4

1.7

—

Hypothyroidism, strict autoimmune, 3 medication purchases required

129

559

1.55

5.10

1.8

—

Acquired absence of limb

13.57

5.10

2.4

1.7

—

Other and unspecified urticaria

152

2.31

5.08

1.9

2.0

—

Other/unspecified cytomegaloviral diseases

8.43

5.07

3.5

2.2

—

Gonarthrosis,primary

139

548

1.53

5.07

1.8

—

DVT of lower extremities

165

2.25

5.05

1.9

1.7

—

Methotrexate

2.76

5.03

1.8

—

Epilepsy

244

2.00

5.01

1.6

1.8

—

Other and unspecified dermatitis

461

1.72

4.97

2.2

1.7

—

Drug-induced cataract

6.94

4.96

2.4

2.0

—

Rare circulating lymphoid malignancy, including Hilmo

6.93

4.95

2.3

1.9

—

Malignant neoplasm, including Hilmo

116

426

1.59

4.92

2.1

1.6

—

Seropositive rheumatoid arthritis

225

2.04

4.92

1.7

—

Inflammatory disease of uterus

2.86

4.91

1.8

1.9

—

Ischemic heart diseases

122

465

1.56

4.88

1.9

1.8

—

Other disorders of nervous system

3.35

4.88

1.7

2.1

—

Infections with a predominantly sexual mode of transmission, including avohilmo

225

1.99

4.88

1.9

—

Gout, unspecified

207

2.08

4.88

2.7

1.8

—

Lumbar disc prolapse

378

1.69

4.85

1.7

1.9

—

Malignant neoplasm, wide definition

116

428

1.58

4.83

2.1

1.6

—

Visual disturbances

451

1.71

4.80

1.6

1.7

—

Spinal stenosis

344

1.71

4.80

1.6

1.9

—

Infliximab

11.52

4.79

2.0

—

Atopic dermatitis

368

1.71

4.77

1.8

—

Exclusions for E4_PCOS_CONSORTIUM

101

389

1.62

4.76

1.8

—

Disorders of calcium metabolism

3.59

4.76

1.3

1.7

—

Hard cardiovascular diseases

117

441

1.57

4.76

1.9

1.8

—

Diseases of tongue

3.58

4.76

2.1

1.9

—

Bronchiectasis

2.89

4.76

2.0

1.6

—

Hyperkinetic disorders, excluding more controls

4.84

4.75

1.9

2.0

—

Valvular heart disease excluding rheumatic fever

276

1.79

4.73

1.7

—

Dental caries, including avohilmo

112

360

1.59

4.73

1.8

—

Non-rheumatic valve diseases

276

1.78

4.72

1.7

—

Other arthrosis

278

1.76

4.72

1.9

1.8

—

Urticaria

217

2.03

4.69

2.0

1.9

—

Antihypertensive medication - note that there are other indications

172

1.88

4.68

2.0

1.9

—

Spirochaetal infections, other/unspecified

3.03

4.66

1.9

2.0

—

Viral and other specified intestinal infections

2.60

4.66

1.7

—

Cyst of Bartholin Gland

7.18

4.65

1.8

1.9

—

Disorders of the thyroid gland

137

593

1.50

4.65

1.8

—

Malignant neoplasm of digestive organs, including Hilmo

303

1.75

4.63

1.8

1.6

—

Postmenopausal bleeding

108

2.14

4.63

1.4

1.9

—

Misadventures to patients during surgical and medical care

103

2.53

4.62

2.0

1.7

—

Bacterial pneumoniae

257

1.88

4.62

1.5

1.6

—

Restless leg syndrome

109

2.48

4.61

1.8

1.9

—

Cholangitis (primary sclerosing, PSC)

3.50

4.61

1.5

2.2

—

Otitis externa, unspecified

2.76

4.60

2.1

—

Corns and callosities

3.35

4.60

1.6

1.9

—

Secondary and unspecified malignant neoplasm of lymph nodes

2.91

4.60

1.9

1.8

—

Other and unspecified tonsillitis

125

2.26

4.59

2.0

—

KRA_PSY_EATING, excluding more controls

5.41

4.56

1.8

1.7

—

Other/unspecified rheumatoid arthritis

110

2.46

4.53

1.7

1.8

—

Other condition

110

2.46

4.53

2.0

—

Lung cancer and mesothelioma

2.49

4.51

2.3

1.6

—

Gonarthrosis [arthrosis of knee](FG)

105

381

1.59

4.49

1.7

—

Dementia, including avohilmo

376

1.63

4.48

1.5

1.8

—

Superficial injury of shoulder and upper arm

2.65

4.48

3.4

1.9

—

Benign neoplasm: Transverse colon

2.59

4.46

1.9

2.1

—

Other diseases of hard tissues of teeth

250

1.70

4.46

1.7

1.8

—

Other degenerative diseases of the nervous system

153

2.05

4.45

1.6

1.9

—

Exclusions for E4_PCOS_BROAD

117

2.40

4.45

1.8

2.0

—

Use of donepezil

258

1.89

4.41

1.7

1.8

—

Speech disturbances, not elsewhere classified

2.69

4.41

1.7

1.9

—

Spondylopathies (FG)

2.69

4.41

2.6

2.0

—

Osteoporosis with pathological fracture (FG)

2.83

4.38

1.7

1.8

—

Artificial joint operation, meniscal resection

134

577

1.49

4.37

1.8

—

Late syphilis

7.61

4.37

1.6

1.8

—

Other diseases of intestine

100

2.50

4.36

2.1

2.0

—

Other disorders of patella

100

2.50

4.36

1.8

1.9

—

Superficial injury of hip and thigh

144

2.23

4.32

3.0

1.9

—

Acute pancreatitis

157

2.17

4.32

2.7

1.9

—

Pleural effusion

151

2.19

4.29

1.9

1.8

—

Motor- or nonmotor-vehicle accident, type of vehicle unspecified

11.78

4.28

2.1

2.3

—

Coeliac disease

2.70

4.24

1.7

2.0

—

Pollen allergy

2.52

4.24

1.6

2.0

—

Reactive arthropathies

3.04

4.23

2.0

2.1

—

Other viral diseases, not elsewhere classified, including avohilmo

177

2.08

4.23

2.3

1.8

—

Allergic contact dermatitis

2.56

4.21

1.8

1.9

—

Acute peritonitis

3.15

4.20

2.7

1.9

—

Non-Hodgkin lymphoma, all

3.87

4.19

1.9

1.8

—

Osteonecrosis

3.43

4.18

2.1

1.7

—

Obsessive-compulsive disorder

4.81

4.18

2.3

1.6

—

Bacterial pneumonia, not elsewhere classified

248

1.84

4.14

1.4

1.6

—

Sudden idiopathic hearing loss

2.60

4.13

1.7

2.1

—

Inflammatory diseases of prostate (prostatitis)

2.59

4.13

1.6

1.9

—

Ulcerative ileocolitis

5.91

4.13

2.5

1.9

—

Benign neoplasm: Caecum

103

2.44

4.13

1.9

2.0

—

Kidney transplant status

4.35

4.12

4.2

1.8

—

Benign neoplasm: Skin of other and unspecified parts of face

2.53

4.12

1.4

2.0

—

Sulfonylureas

317

1.71

4.12

1.8

—

Gout, idiopatic and unspecified

264

1.86

4.10

2.7

1.7

—

Artrosis, including avohilmo

112

401

1.53

4.09

1.6

1.9

—

Diabetic nephropathy

159

2.12

4.07

2.8

1.7

—

Anti-inflammatory and antirheumatic products, non-steroids

2.15

4.06

2.2

1.9

—

Gonarthrosis, primary, with knee surgery

474

1.56

4.06

1.7

1.8

—

Gonarthrosis

304

1.62

4.05

1.7

1.8

—

Fracture of lower leg, including ankle

480

1.62

4.05

1.9

1.7

—

Paroxysmal tachycardia

2.36

4.04

1.8

—

Hyperplasia of prostate

144

1.92

4.02

1.7

1.9

—

Arthropathy in ulcerative colitis

10.12

4.02

2.1

1.9

—

Conductive and sensorineural hearing loss

119

530

1.49

4.02

2.0

1.8

—

ILD, hospital admissions 3, with pneumonia sepsis

2.76

4.01

2.0

1.6

—

Nail disorders

2.94

4.00

1.7

2.2

—

Other disorders of glucose regulation and pancreatic internal secretion

2.94

4.00

1.6

1.9

—

Chronic rhinitis, nasopharyngitis and pharyngitis

245

1.88

3.99

1.6

1.8

—

Cervical disc disorders

281

1.82

3.98

1.6

1.9

—

Major coronary heart disease event

123

497

1.48

3.95

1.9

1.8

—

Tongue abnormality

3.14

3.93

2.1

2.0

—

Malignant neoplasm of digestive organs

292

1.70

3.91

1.7

1.6

—

Superficial injury of wrist and hand

144

2.16

3.91

2.2

1.9

—

Fracture of shoulder and upper arm

349

1.72

3.89

1.6

1.8

—

Other complications of surgical and medical care, not elsewhere classified

2.89

3.89

2.4

1.9

—

Chronic lower respiratory diseases

164

615

1.40

3.89

2.0

1.8

—

Open wound of forearm

2.64

3.89

3.1

2.1

—

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

125

2.24

3.88

1.7

—

Other disorders of breast

100

2.41

3.88

2.0

1.9

—

Vitreous haemorrhage

2.57

3.88

1.8

2.0

—

Burn and corrosion of wrist and hand

4.81

3.87

1.5

2.2

—

Mature T/NK-cell lymphomas, hilmo

7.37

3.87

2.5

1.6

—

Other and unspecified follicular disorders

4.81

3.87

2.0

1.8

—

Percutaneous Coronary Intervention

113

459

1.50

3.85

1.8

—

Irregular menses

249

1.75

3.83

1.8

—

Delirium, not induced by alcohol and other psychoactive substances

132

2.20

3.83

1.9

—

Late syphilis, including avohilmo

6.07

3.82

1.6

1.9

—

Oxicams

2.22

3.82

1.7

1.9

—

Dementia in Alzheimer disease

195

1.89

3.78

1.6

1.7

—

Striking against or struck by other objects

257

1.83

3.76

2.3

1.8

—

Abnormal involuntary movements

108

2.32

3.75

2.0

—

Protozoal diseases

4.62

3.75

2.5

2.0

—

Congenital iodine-deficiency syndrome/hypothyroidism

4.62

3.75

1.7

2.0

—

UC patients in KELA-register (code 208), prior to 1994

4.61

3.74

2.2

1.9

—

396

1.65

3.74

2.0

1.7

—

Colectomy operation

167

2.04

3.74

2.4

1.9

—

Seropositive rheumatoid arthritis, wide

251

1.84

3.73

1.7

1.8

—

Metatarsalgia

2.92

3.73

1.6

2.1

—

Bitten or struck by other mammals

2.64

3.72

1.5

2.1

—

Other bursopathies

2.40

3.71

1.8

2.0

—

Migraine without aura and triptan purchases

2.45

3.70

1.6

1.8

—

Other viral diseases, not elsewhere classified

121

2.23

3.69

2.4

1.9

—

Amputation of ankle bones

5.04

3.69

2.2

2.0

—

Symptoms and signs involving speech and voice

311

1.74

3.67

1.9

1.8

—

Pneumocystosis, including avohilmo

5.68

3.66

2.7

1.9

—

Pneumocystosis

5.68

3.66

2.7

1.9

—

Coronary revascularization (ANGIO or CABG)

112

459

1.48

3.66

1.8

—

Calculus of lower urinary tract

3.12

3.65

2.1

1.8

—

Lymphoid leukaemia

3.12

3.65

2.1

1.9

—

Traumatic subdural haemorrhage

2.34

3.64

1.9

2.0

—

Asthma-related infections

584

1.52

3.61

2.2

1.7

—

Asthma, hospital admission 2, infections

584

1.52

3.61

2.2

1.7

—

Gout, strict definition

190

1.95

3.61

2.7

1.7

—

Obesity related asthma

313

1.73

3.60

2.4

1.7

—

Vasomotor rhinitis (mode)

2.95

3.57

2.1

2.0

—

Weight loss

2.40

3.55

1.8

2.0

—

Cardiovascular diseases

161

1.78

3.54

2.1

1.9

—

Injuries to the wrist and hand

136

638

1.41

3.53

2.1

1.8

—

Arthrosis

323

1.54

3.53

1.6

1.8

—

Myocardial infarction, without ST-elevation

414

1.59

3.52

2.3

1.8

—

Diagnoses used for exclusion with ILD

249

1.81

3.51

2.1

1.8

—

Protozoal diseases, including avohilmo

4.26

3.51

2.5

1.9

—

Sleep disorders

124

596

1.43

3.50

1.7

1.8

—

Agoraphobia

10.03

3.50

2.7

1.3

—

Ingrowing nail

3.63

3.49

1.8

2.1

—

Intestinal malabsorption

3.89

3.49

2.3

1.9

—

Benign neoplasm: Ascending colon

138

2.11

3.48

1.7

1.9

—

Spondylosis

358

1.59

3.47

1.8

1.9

—

Phlebitis and thrombophlebitis (not including DVT)

193

1.92

3.46

2.1

1.7

—

Other neurological diseases

111

593

1.45

3.43

1.8

—

Adhesive capsulitis of shoulder

119

2.19

3.43

1.5

1.9

—

Dermatophytosis, including avohilmo

555

1.52

3.43

1.9

1.8

—

Chondrocostal junction syndrome [Tietze]

4.57

3.43

1.3

2.1

—

Other enthesopathy of foot (+metatarsalgia)

2.76

3.41

1.6

2.1

—

Hypothyroidism, drug reimbursement

3.99

3.39

1.8

1.6

—

Sub-endpoint used in defining T1D endpoints

248

1.79

3.38

2.4

1.8

—

Flat foot [pes planus] (acquired)

2.58

3.37

1.4

2.0

—

Vascular disorders of the intestines

3.10

3.36

1.7

—

L01XX Other antineoplastic agents

2.84

3.35

2.3

2.0

—

Chondromalacia

5.75

3.34

2.5

2.1

—

Recurrent aphthous stomatitis , including avohilmo

114

2.20

3.34

2.1

2.0

—

Other disorders of veins

383

1.62

3.33

1.6

1.7

—

Other diseases of gallbladder

3.44

3.31

2.2

1.9

—

Other extrapyramidal and movement disorders in other diseases

240

1.79

3.29

1.8

—

Generalized skin eruption due to drugs and medicaments

3.95

3.29

2.1

2.0

—

Suppurative and unspecified otitis media

205

1.82

3.27

1.9

—

Mantle cell lymphoma, including Hilmo

8.65

3.27

1.7

1.9

—

L01XE Protein kinase inhibitors

3.04

3.25

2.5

1.8

—

Tonsillectomy and adenotomy

242

1.67

3.25

1.9

—

Problems related to lifestyle

2.78

3.25

1.7

2.0

—

Medical abortion

304

1.53

3.24

1.6

1.7

—

Syphilis

4.77

3.24

1.6

1.7

—

Syphilis, including avohilmo

4.77

3.24

1.6

1.7

—

Hallux valgus (acquired)

201

1.74

3.23

1.4

1.8

—

Conjunctivitis (acute, non atopic), including avohilmo

136

590

1.39

3.22

1.6

1.9

—

Assault

2.67

3.22

2.4

1.8

—

Other/unspecified synovitis and tenosynovitis

2.50

3.20

1.4

2.0

—

Alzheimer disease, excluding more controls

2.13

3.20

1.7

—

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, including Hilmo

4.19

3.20

1.7

2.0

—

Chronic lymphocytic leukaemia, helper endpoint

4.19

3.20

1.7

2.0

—

Chronic lymphocytic leukaemia

4.19

3.20

1.7

2.0

—

Enteropathic arthropathies

5.37

3.19

2.0

2.1

—

Primary hyperparathyroidism

2.27

3.19

1.7

1.8

—

Alcohol abuse, main dg

2.27

3.19

2.0

—

Spondyloarthritis

123

2.12

3.18

2.6

1.8

—

Eating disorder

3.53

3.18

1.8

2.0

—

Acute pancreatitis (for exclusion)

178

1.91

3.17

2.7

1.8

—

Gingivitis and periodontal diseases

141

526

1.38

3.16

1.8

—

Lichen simplex chronicus and prurigo

3.26

3.13

1.8

2.1

—

Neuromuscular dysfunction of bladder

2.63

3.13

1.8

2.1

—

Insulin, fast-acting (human)

2.41

3.13

1.8

—

Other (seronegative) rheumatoid arthritis, wide

165

1.94

3.13

1.7

1.9

—

Diabetic retinopathy, excluding more controls

136

1.81

3.12

1.8

1.5

—

Ménière disease

2.47

3.12

1.9

2.0

—

Glomerulonephritis

2.47

3.12

2.5

2.2

—

Pneumonia due to other infectious organisms, not elsewhere classified

4.52

3.11

2.6

2.0

—

Open bite

4.51

3.11

2.1

1.9

—

Carcinoma in situ of skin of lower limb, including hip

4.04

3.09

1.3

2.1

—

Other enthesopathies

223

1.80

3.08

2.1

1.8

—

Chronic nephritic syndrome

4.02

3.08

2.6

1.8

—

Abscess of anal and rectal regions

3.67

3.08

3.9

2.2

—

Disorders of skin appendages

419

1.57

3.08

1.8

—

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

2.36

3.07

1.7

2.1

—

Asthma, hospital admissions 3, pneumonia

397

1.58

3.06

2.3

1.7

—

Asthma-related pneumonia or sepsis

397

1.58

3.06

2.3

1.7

—

N06DA Anticholinesterases

353

1.55

3.06

1.7

1.8

—

Use of anticholinesterases

353

1.55

3.06

1.7

1.8

—

Hyperhidrosis

7.52

3.05

1.2

1.9

—

Disorders of oesophagus in diseases classified elsewhere

5.04

3.05

2.1

1.6

—

SLE (Finngen)

5.02

3.05

1.9

2.1

—

Other diseases of biliary tract

2.44

3.04

1.9

—

Toxic effects of substances chiefly nonmedicinal as to source

2.50

3.03

2.6

2.1

—

Use of pramipexole

210

1.81

3.03

1.8

—

Other problems related to primary support group, including family circumstances

2.78

3.02

2.8

1.9

—

Diseases of male genital organs

168

1.68

3.02

2.0

1.9

—

Behavioural syndromes associated with physiological disturbances and physical factors

124

603

1.39

3.02

1.7

1.8

—

Special screening examination for other diseases and disorders

2.89

3.01

2.3

1.8

—

Insomnia

119

592

1.40

3.00

1.7

1.8

—

Bacterial meningitis

4.31

2.99

2.4

1.9

—

Other hammer toe(s) (acquired)

139

1.97

2.99

1.4

1.8

—

Alzheimer’s disease (Late onset), excluding more controls

2.17

2.99

1.5

1.6

—

Dementia

357

1.51

2.99

1.5

1.7

—

Immunodeficiencies

3.56

2.99

4.2

1.9

—

Vitamin deficiency

3.56

2.99

1.8

2.0

—

Vitamin deficiency, wide

3.56

2.99

1.8

2.0

—

Cutis laxa senilis

10.15

2.99

1.4

2.4

—

Ovarian dysfunction

3.56

2.99

3.0

1.7

—

Flatulence and related conditions

10.10

2.98

1.6

1.8

—

Solid cancers

103

419

1.44

2.98

1.9

1.6

—

Other/unspecified seropositive rheumatoid arthritis

248

1.74

2.98

1.7

1.8

—

Zoster [herpes zoster], including avohilmo

519

1.49

2.95

1.9

1.7

—

Disturbance of activity and attention

2.74

2.94

1.9

—

Wide developmental disorders, excluding more controls

9.78

2.93

2.2

1.4

—

Ovarian cyst

134

1.79

2.93

1.5

2.0

—

Other diseases of peritoneum

3.45

2.90

2.3

1.9

—

Other noninflammatory disorders of cervix uteri

3.45

2.90

1.5

2.3

—

Event of undetermined intent

3.45

2.89

1.7

2.1

—

Ischaemic heart disease, wide definition

108

469

1.42

2.89

1.8

—

Myelodysplastic syndrome, including Hilmo

4.11

2.88

1.8

1.9

—

Bulimia nervosa (incl. atypical)

5.40

2.87

1.9

1.8

—

Other embolism and thrombosis

102

2.16

2.86

2.5

1.8

—

Dermatitis due to substances taken internally

3.17

2.85

2.0

1.9

—

Disorders of synovium and tendon

356

1.55

2.84

1.5

1.8

—

Asthma-related pneumonia

397

1.56

2.84

2.2

1.7

—

Malignant neoplasm of skin, including Hilmo

327

1.52

2.83

1.7

1.6

—

Chronic periodontitis, complicated

498

1.49

2.82

1.8

—

Macular hole

2.78

2.81

1.2

2.0

—

Other necrotizing vasculopathies (FG)

2.78

2.81

1.7

2.0

—

Malignant neoplasm of other connective and soft tissue

4.47

2.80

1.5

2.2

—

Seronegative rheumatoid arthritis

2.23

2.79

1.8

2.0

—

Lung diseases due to external agents

144

1.95

2.79

1.9

—

Hypertensive Renal Disease

3.59

2.78

2.1

1.8

—

Barrett oesophagus

3.58

2.78

2.1

1.8

—

Disease of hard tissues of teeth, NOS

229

1.56

2.77

1.6

1.8

—

Postprocedural disorders of digestive system, not elsewhere classified

3.93

2.77

2.6

1.9

—

Coronary atherosclerosis

417

1.44

2.77

1.8

—

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

129

2.00

2.77

1.6

1.7

—

Other disorders of white blood cells

3.09

2.77

2.4

1.9

—

Abrasion of teeth

315

1.62

2.77

1.5

1.8

—

Abnormal weight loss

2.27

2.76

1.9

—

Hypopituitarism

3.08

2.76

1.9

2.1

—

Car occupant injured in other and unspecified transport accidents

124

2.02

2.75

2.4

2.0

—

Myeloproliferative diseases

2.31

2.74

2.7

2.0

—

Other pleural conditions

104

2.12

2.74

2.3

1.8

—

Acidosis

5.03

2.73

3.3

1.9

—

Acute myeloid leukaemia and myelodysplastic syndromes

5.03

2.73

3.9

2.1

—

Other disorders of bone density and structure

5.03

2.73

2.7

2.0

—

Fall on same level involving ice and snow

556

1.46

2.73

1.8

1.7

—

Acute generalized exanthematous pustulosis

3.25

2.72

2.1

2.0

—

Acute pharyngitis

2.52

2.72

2.2

1.7

—

Olecranon bursitis

3.24

2.72

1.6

2.2

—

Seborrhoeic dermatitis

2.37

2.72

1.8

2.0

—

Malignant neoplasm of skin

323

1.51

2.72

1.8

1.6

—

Fracture of foot, except ankle

174

1.84

2.71

2.0

1.9

—

Disorders of sclera, cornea, iris and ciliary body

500

1.48

2.71

1.8

—

Eating disorders

2.71

2.70

2.1

—

Benign neoplasm: Short bones of upper limb

6.05

2.70

1.2

2.0

—

Drug-induced hypoglycaemia without coma

6.04

2.70

1.8

—

Disorders of vitreous body and globe

488

1.47

2.69

1.8

1.7

—

Other disorders of ear

122

577

1.37

2.69

1.8

—

Endometriosis

136

1.75

2.69

1.6

2.0

—

Artificial opening status

3.46

2.69

2.6

1.7

—

4.24

2.68

2.3

2.0

—

Other obstetric trauma

4.22

2.67

2.5

1.8

—

Failed induction of labour

4.22

2.67

2.9

1.9

—

Chronic tubulo-interstitial nephritis

3.76

2.67

2.7

1.9

—

Retinal detachment with retinal break

112

2.06

2.66

1.5

1.9

—

Hyperkinetic disorders

2.58

2.65

1.9

—

Diabetic maculopathy, excluding more controls

2.33

2.64

1.5

1.9

—

Monoamine oxidase A inhibitors

2.33

2.64

1.9

1.8

—

Fall involving bed

3.16

2.64

2.5

1.9

—

Alcohol-induced chronic pancreatitis

2.80

2.64

1.9

2.2

—

Erosion of teeth , including avohilmo

183

1.81

2.64

1.9

—

Hyperlipidaemia, other/unspecified

314

1.58

2.63

2.0

1.7

—

Idiopathic gout

2.22

2.63

2.8

1.8

—

Burns and corrosions

2.21

2.63

1.6

2.0

—

Superficial injury of head

220

1.73

2.62

1.4

1.9

—

Ankylosing spondylitis

2.66

2.62

2.4

2.2

—

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

243

1.69

2.62

1.7

1.8

—

Solid cancers, including Hilmo

102

423

1.41

2.62

1.9

1.6

—

Inflammatory disease of cervix uteri

2.94

2.62

1.4

1.8

—

Other and unspecified drugs and medicaments

2.46

2.61

1.9

2.1

—

Use of disulfiram, acamprosate or naltrexone

2.93

2.61

1.8

2.0

—

Simple and mucopurulent chronic bronchitis

3.35

2.60

2.1

1.8

—

Pilonidal cyst

3.34

2.60

2.0

—

Congenital ovarian cysts

4.68

2.59

1.6

1.9

—

Later onset COPD

262

1.60

2.58

1.7

1.8

—

Other sexually transmitted chlamydial diseases

3.61

2.57

2.3

1.9

—

Polycystic ovarian syndrome

4.01

2.56

3.4

1.9

—

Other and unspecified types of non-Hodgkin lymphoma, hilmo

3.07

2.56

2.0

2.1

—

Disorders of vitreous body

481

1.46

2.56

1.8

1.7

—

Other infective otitis externa

3.06

2.56

1.3

2.0

—

Chronic myeloproliferative disease

7.20

2.55

2.8

1.6

—

Colitis, primary sclerosing

7.20

2.55

1.8

2.3

—

Viral warts

2.36

2.55

2.0

2.2

—

Atrial septal defect

3.99

2.55

2.1

—

Drug-induced osteoporosis

5.50

2.55

2.0

1.8

—

Open wound of lower leg

121

1.99

2.54

2.0

1.9

—

Certain disorders involving the immune mechanism

142

1.90

2.54

2.9

1.9

—

Viral pneumonia (unknown virus, not influenza)

2.73

2.54

2.3

2.2

—

Other and unspecified rosacea

2.42

2.53

1.9

2.1

—

Other noninflammatory disorders of vagina

2.61

2.53

1.5

2.1

—

Other contact dermatitis

2.61

2.53

1.6

2.0

—

Diabetic retinopathy

216

1.58

2.52

1.7

1.9

—

Other and unspecified disorders of white blood cells

3.24

2.52

2.3

1.9

—

Right bundle-branch block

3.24

2.52

1.1

1.7

—

Malignant neoplasm of mesothelium and soft tissue

3.24

2.52

1.8

2.0

—

Meningitis

3.24

2.51

2.4

2.0

—

Focal brain injury

3.23

2.51

2.2

2.1

—

Congenital malformations of genital organs

2.71

2.51

1.9

2.0

—

Emergency coronary revascularization (for ACS)

120

535

1.35

2.50

1.8

—

Atopic dermatitis, strict definition with reimbursement

158

1.82

2.48

1.7

1.9

—

Sacroiliitis, not elsewhere classified

3.47

2.48

2.8

1.9

—

Drug-induced osteoporosis with pathological fracture

4.41

2.48

2.3

1.9

—

Immunodeficiency with predominantly antibody defects

4.40

2.47

5.9

2.1

—

Anomalies of dental arch relationship, including avohilmo

104

2.00

2.46

1.8

2.0

—

Noninflammatory disorders of female genital tract

139

1.66

2.45

1.8

2.0

—

Single spontaneous delivery

224

0.52

2.44

2.4

1.7

—

Follow-up examination after treatment for malignant neoplasms

2.55

2.44

2.0

1.7

—

L04AC Interleukin inhibitors

3.13

2.43

2.2

2.1

—

Assault by bodily force

3.13

2.43

2.0

1.8

—

Any dementia, excluding more controls

276

1.52

2.41

1.5

1.7

—

Benign neoplasm: Other/unspecified site

5.04

2.40

2.5

1.8

—

Congenital malformations of ovaries, fallopian tubes and broad ligaments

3.34

2.39

1.7

1.9

—

Rheumatoid arthritis, including avohilmo

368

1.52

2.38

1.7

1.8

—

Abnormal results of function studies

2.35

2.38

1.7

1.9

—

Care involving use of rehabilitation procedures

477

0.58

2.38

1.5

1.8

—

Malignant neoplasm of eye and adnexa, including Hilmo

6.29

2.37

5.4

1.9

—

Other/unspecified enthesopathies, not elsewhere classified

2.42

2.36

3.0

2.1

—

SLE, strict definition

3.65

2.36

1.9

2.0

—

SLE, ICD10

3.65

2.36

1.9

2.0

—

Systemic lupus erythematosus

3.65

2.36

1.9

2.1

—

Status epilepticus

3.65

2.36

1.9

2.0

—

Acute laryngitis and tracheitis

2.51

2.36

1.5

1.9

—

Acquired haemolytic anaemia

4.14

2.36

2.3

1.9

—

Hypoparathyroidism

3.04

2.36

1.4

1.9

—

Reactive arthropathies, FINNGEN

2.61

2.35

2.0

2.3

—

Hypoglycaemia, other or unspecified

2.61

2.35

1.8

1.9

—

Cervicalgia

176

1.76

2.33

2.0

1.9

—

Chronic periodontitis, including avohilmo

130

629

1.32

2.32

1.7

1.8

—

Malignant melanoma, including Hilmo

140

1.86

2.31

2.4

1.7

—

Adrenocortical insufficiency

3.23

2.31

2.0

—

AV-block

131

1.83

2.30

2.0

1.8

—

Deviated nasal septum

237

1.64

2.29

2.0

1.8

—

Complications following infusion, transfusion and therapeutic injection

4.65

2.27

3.3

1.8

—

Drug-induced neutropenia

2.46

2.27

2.1

—

Primary biliary cholangitis, wide definition

4.64

2.27

1.8

2.2

—

Hepatocellular carcinoma

4.64

2.27

1.5

1.8

—

Benign neoplasm: Liver

4.64

2.27

1.8

2.0

—

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

4.63

2.27

2.2

2.0

—

Myeloid leukaemia

3.50

2.27

4.5

1.8

—

Thyroiditis, ILD-related definition

2.23

2.27

1.7

1.9

—

Malignant neoplasm of liver and intrahepatic bile ducts

3.49

2.27

1.6

2.1

—

Injury of other and unspecified intrathoracic organs

2.56

2.27

1.8

—

Other diseases of liver

141

1.85

2.26

2.0

1.9

—

Periodontitis

130

631

1.31

2.26

1.7

1.8

—

Other crystal arthropathies

3.91

2.25

1.7

—

Coxarthrosis [arthrosis of hip](FG)

349

1.44

2.25

1.8

1.7

—

Other obstructive and reflux uropathy

3.90

2.25

2.4

1.8

—

Maltreatment syndromes

3.90

2.25

3.1

1.7

—

Nonorganic sleeping disorders

156

1.80

2.24

2.0

1.9

—

Benign neoplasm: Skin, unspecified

3.11

2.22

1.8

2.1

—

Oesophageal varices

3.11

2.22

2.2

2.0

—

Other specified/unspecified necrotizing vasculopathies

5.60

2.22

2.0

2.1

—

Atrial fibrillation and flutter

108

1.79

2.21

2.4

1.8

—

Other gastritis (incl. Duodenitis)

179

1.73

2.21

1.8

1.7

—

Other and unspecified effects of external causes

194

1.70

2.21

1.8

1.9

—

Corneal ulcer

135

1.85

2.21

1.9

2.0

—

Myocardial infarction

357

1.43

2.18

2.2

1.8

—

Stenosis and insufficiency of lacrimal passages

2.13

2.18

1.6

1.9

—

Fracture of skull and facial bones

165

1.76

2.18

1.7

1.8

—

Cerebral palsy and other paralytic syndromes

2.13

2.18

1.7

2.0

—

Iridocyclitis

195

1.69

2.18

1.6

1.9

—

Urolithiasis

296

1.56

2.18

2.1

1.8

—

Disorders of conjunctiva

106

614

1.34

2.17

1.7

1.8

—

Spondylopathies in diseases classified elsewhere

4.33

2.15

1.8

2.1

—

Portal vein thrombosis

4.32

2.15

4.2

1.7

—

Deficiency of other B group vitamins

4.31

2.15

1.3

1.9

—

Unspecified event, undetermined intent

4.30

2.15

1.7

2.1

—

Intentional self-harm by sharp object

4.30

2.15

2.0

—

Impetigo

3.69

2.15

1.6

1.8

—

Other/unspecified enthesopathies of lower limb, excluding foot

2.62

2.14

1.3

2.3

—

255

1.58

2.13

1.9

1.7

—

Arthropathic psoriasis

2.10

2.12

1.8

2.2

—

Coxarthrosis

283

1.46

2.12

1.8

—

Disorders of continuity of bone

2.37

2.12

1.5

1.8

—

Duodenal ulcer

2.05

2.11

1.5

1.7

—

Dermatophytosis

109

1.93

2.10

2.0

1.9

—

Viral pneumonia (known virus, not influenza)

3.22

2.09

2.0

2.1

—

Other respiratory diseases principally affecting the interstitium

190

1.69

2.09

2.3

1.8

—

Type 1 diabetes, strict (exclude DM2)

3.19

2.08

2.4

2.3

—

Type 1 diabetes, definitions combined

3.19

2.08

2.4

2.3

—

Diseases of middle ear and mastoid

396

1.42

2.08

2.0

1.8

—

Other necrotizing vasculopathies

2.26

2.07

2.4

1.9

—

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

2.26

2.07

2.4

2.0

—

Psoriatic arthropathies

2.26

2.07

1.7

2.0

—

Crossbite

3.21

2.07

2.4

1.9

—

Superficial injury of neck

5.02

2.07

2.2

2.1

—

Dislocation, sprain and strain of joints and ligaments of knee

425

1.43

2.07

1.8

—

Abnormal findings on examination of blood, without diagnosis

403

1.44

2.07

2.2

1.8

—

Other disorders of adrenal gland

2.91

2.07

2.0

—

Disorders of breast

399

1.43

2.07

1.8

—

Dementia in other diseases classified elsewhere

2.71

2.07

1.6

1.8

—

Wide developmental disorders

4.99

2.06

2.2

2.5

—

Nephrotic syndrome

3.51

2.05

1.6

2.0

—

Bacterial pneumonia (organism specified)

427

1.42

2.04

1.7

1.8

—

Nummular dermatitis

2.33

2.04

2.1

2.2

—

Myeloproliferative diseases (CML excluded)

2.18

2.04

2.4

2.0

—

Perforation of tympanic membrane

2.18

2.04

2.5

2.0

—

Unspecified nephritic syndrome

4.02

2.04

3.2

1.9

—

Benign neoplasm: Liver/bile ducts

4.02

2.04

1.8

1.9

—

Other malignant neoplasms of skin (=non-melanoma skin cancer)

312

1.44

2.04

1.8

1.6

—

Hidradenitis suppurativa

4.01

2.04

1.7

1.9

—

Unspecific neurodegenerative disorder

373

1.40

2.01

1.7

1.8

—

Mixed hyperlipidaemia

3.09

2.01

1.9

1.8

—

Residual foreign body in soft tissue

3.08

2.01

1.6

2.4

—

Malignant neoplasm of liver and intrahepatic bile ducts, including Hilmo

2.51

2.01

1.7

2.0

—

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

2.51

2.01

1.7

1.9

—

Viral infections of the central nervous system

2.51

2.01

1.8

2.1

—

Major coronary heart disease event excluding revascularizations

432

1.36

2.01

1.8

1.7

—

Temporal arteritis

2.82

2.00

1.4

1.8

—

Other vitreous opacities

2.82

2.00

1.8

2.1

—

Ankylosing spondylitis, ICD10

2.29

1.97

2.4

2.0

—

Other and unspecified injuries of shoulder and upper arm

3.34

1.96

1.3

2.0

—

Lichen simplex chronicus

3.34

1.96

2.0

1.9

—

Open wound of hip and thigh

3.34

1.96

5.0

1.9

—

Other disorders of amniotic fluid and membranes

2.28

1.96

2.3

1.8

—

Personality disorders

171

1.70

1.95

2.2

1.9

—

Acute bronchiolitis

3.87

1.95

2.7

1.9

—

Septal defects

2.76

1.94

2.1

—

Rosacea

1.98

1.94

1.8

2.1

—

Triptan medication for migraine, min. 3 purchases

311

1.44

1.94

2.0

1.8

—

Disorders of orbit

2.97

1.93

2.1

2.0

—

Other puerperal infections

2.97

1.93

2.5

1.8

—

Postmenopausal atrophic vaginitis

107

1.68

1.93

1.5

1.9

—

Degeneration of macula and posterior pole

445

1.37

1.93

1.8

—

Benign neoplasm: Skin of ear and external auricular canal

2.74

1.93

1.3

2.0

—

Inflammatory disorders of breast

2.73

1.93

1.9

—

Other/unspecified reactive arthropathies

2.45

1.93

2.0

2.1

—

Ulcer of oesophagus

2.45

1.93

3.6

1.6

—

Other sexually transmitted chlamydial diseases, including avohilmo

2.45

1.93

2.4

2.2

—

Injuries to the elbow and forearm

599

1.33

1.91

2.2

1.8

—

Appendectomy

528

1.37

1.91

2.1

1.8

—

Chronic suppurative otitis media, including avohilmo

2.25

1.90

1.5

2.0

—

Inflammatory diseases of the central nervous system

2.25

1.90

2.2

2.1

—

Alzheimer’s disease (Atypical or mixed), excluding more controls

2.10

1.90

2.1

1.6

—

Mixed conductive and sensorineural hearing loss

106

1.89

1.90

2.0

—

Congenital malformations of heart and great arteries

2.11

1.90

1.9

—

Benign neoplasm of other and unspecified sites

3.19

1.88

2.4

1.9

—

Other specified/unspecified inflammatory spondylopathies

3.19

1.88

3.7

2.4

—

Salpingitis and oophoritis

121

1.82

1.87

1.7

—

Acute and transient psychotic disorders

2.16

1.87

1.4

2.0

—

Other obstetric conditions, not elsewhere classified

1.79

1.87

2.0

1.8

—

Acute lymphadenitis

2.86

1.86

1.8

2.2

—

Motorcycle rider injured in other and unspecified transport accidents

2.86

1.86

2.0

2.3

—

Other and unspecified mood [affective] disorders

2.86

1.86

1.4

1.9

—

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

2.09

1.86

1.7

1.9

—

Transient ischemic attack

443

1.37

1.85

1.8

—

Benign neoplasm of other and unspecified endocrine glands

100

1.90

1.85

2.1

2.0

—

ILD, hospital admissions

159

1.70

1.84

2.1

1.9

—

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

317

1.41

1.84

1.8

1.6

—

Malnutrition

3.55

1.84

2.2

1.9

—

Other endocrine disorders

2.84

1.84

1.6

2.0

—

Asthma/COPD (KELA code 203)

118

614

1.28

1.83

2.1

1.8

—

Nonsuppurative otitis media

118

1.77

1.82

2.3

1.9

—

Meniscus derangement

290

1.42

1.82

1.7

1.8

—

Other superficial mycoses

4.18

1.82

3.6

2.2

—

Diffuse brain injury

4.18

1.82

1.8

2.2

—

Artificial joint re-operation

2.13

1.82

1.8

2.0

—

Cerebral aneurysm, nonruptured

2.13

1.81

2.6

2.1

—

Nonalcoholic fatty liver disease

2.12

1.81

1.7

2.1

—

Malignant neoplasm of mesothelium and soft tissue, including Hilmo

2.27

1.80

1.7

1.8

—

Open wound of ankle and foot

2.06

1.80

2.0

—

Tuberculosis of other organs, strict

3.06

1.80

2.3

2.0

—

Hepatocellular carcinoma, including Hilmo

3.06

1.80

1.6

1.9

—

Hydronephrosis

2.00

1.79

2.3

1.7

—

Contact with heat and hot substances

2.76

1.79

1.4

2.3

—

Congenital malformations of cardiac septa

2.57

1.78

2.1

2.3

—

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

2.17

1.77

1.8

—

Adalimumab

2.34

1.77

1.7

2.0

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

102

1.87

1.75

1.7

2.0

—

Benign neoplasm: Skin of eyelid, including canthus

139

1.73

1.75

1.6

1.9

—

Psoriasis vulgaris

139

1.73

1.75

1.9

—

Tuberculosis of other organs

3.35

1.75

2.5

2.2

—

Hodgkin lymphoma, hilmo

3.35

1.75

2.2

1.9

—

Juvenile arthritis (FINNGEN)

3.34

1.74

1.8

2.3

—

Giant cell arteritis with polymyalgia rheumatica

2.51

1.74

1.4

1.8

—

Other/unspecified disorders of vestibular function

2.51

1.74

1.6

2.3

—

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Clostridioides difficile [Presence] in Stool

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS